RYHAX Mutual Fund

NAV$125.30

Fund Essentials - as of Mar 31, 2026

Net Assets
$1M
Expense Ratio
1.64%
Dividend Yield (Current)
2.47%
Holdings
136
Inception Date
May 11, 1998
Fund Family
Rydex Funds
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO
Dividend Frequency
Annually

Performance

YTD+4.99%
1 Year+23.65%
3 Year+8.63%
5 Year+4.12%
10 Year+9.17%

Asset Allocation

Stocks: 99.53%
Bonds: 0.47%

Price Chart (6M)

Loading chart data...

Top Holdings

View All →
TickerNameWeight
LLYEli Lilly And Company3.67%
JNJJOHNSON AND JOHNSON3.25%
ABBVAbbvie Inc Health Care2.57%
MRKMerck & Co. Inc.2.34%
UNHUnited Health Group2.09%
Top 10 Concentration: 22.81%Report Date: Mar 31, 2026
Download all 136 holdings for RYHAX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
2.47%
Frequency
Annually
Latest Distribution
$1.41
-

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO
See how RYHAX ranks against its peers
Category rank, peer-average returns and outperformance, updated daily.
$49$29/mo
Claim the $29 launch price
First 500 subscribers, then $49/mo. Cancel anytime. From MarketXLS, trusted since 2014.

RYHAX Mutual Fund Overview

RYHAX Mutual Fund (Rydex Health Care Fund Class H) is managed by Rydex Funds with $1.5M in net assets. RYHAX expense ratio is 1.64%, holding 136 positions across sectors including Health Care, Unknown, Financials. Inception date: 1998-05-11.

RYHAX performance shows a YTD return of 4.99%. The 1-year return is 23.65% and the 5-year return is 4.12%. RYHAX dividend yield stands at 2.47%, paid annually.

RYHAX top holdings include Eli Lilly And Company (3.7%), JOHNSON AND JOHNSON (3.3%), Abbvie Inc Health Care (2.6%), Merck & Co. Inc. (2.3%), United Health Group (2.1%). View all RYHAX holdings, sector breakdown, or dividend history.

RYHAX can be compared against other funds using the overlap calculator or side-by-side comparison tool. RYHAX alternatives are available via the screener, along with tax-loss harvesting opportunities.